Hi Tech Pharmacal Co Inc (HITK) financial statements (2021 and earlier)

Company profile

Business Address 369 BAYVIEW AVENUE
AMITYVILLE, NY 11701
State of Incorp. NY
Fiscal Year End April 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

4/30/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments101
Cash and cash equivalents101
Receivables64
Inventory, net of allowances, customer advances and progress billings39
Inventory39
Other current assets4
Other undisclosed current assets12
Total current assets:220
Noncurrent Assets
Property, plant and equipment32
Intangible assets, net (including goodwill), including:41
Intangible assets, net (excluding goodwill)40
Other undisclosed intangible assets, net (including goodwill)1
Other noncurrent assets0
Other undisclosed noncurrent assets2
Total noncurrent assets:75
TOTAL ASSETS:295
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities28
Accounts payable10
Accrued liabilities14
Employee-related liabilities3
Taxes payable1
Debt0
Other undisclosed current liabilities16
Total current liabilities:44
Noncurrent Liabilities
Long-term debt and lease obligation1
Long-term debt, excluding current maturities1
Other undisclosed noncurrent liabilities5
Total noncurrent liabilities:6
Total liabilities:50
Stockholders' equity
Stockholders' equity attributable to parent245
Common stock0
Treasury stock, value(24)
Additional paid in capital101
Retained earnings168
Total stockholders' equity:245
TOTAL LIABILITIES AND EQUITY:295

Income statement (P&L) ($ in millions)

4/30/2013
Revenues
(Revenue, Net)
232
Cost of revenue
(Cost of Goods and Services Sold)
(117)
Gross profit:115
Operating expenses(84)
Operating income:31
Nonoperating expense(92)
Interest and debt expense(1)
Other undisclosed income from continuing operations before equity method investments, income taxes85
Income from continuing operations before income taxes:23
Income tax expense(7)
Net income available to common stockholders, diluted:16

Comprehensive Income ($ in millions)

4/30/2013
Net income:16
Comprehensive income, net of tax, attributable to parent:16

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: